PRESS RELEASE published on 09/27/2024 at 07:30, 1 year 11 months ago FORVIA FY 2024 guidance update FORVIA adjusts 2024 guidance due to lower production outlook and uncertain environment. Initiatives accelerated to improve 2025 performance in a challenging environment. Key target of net debt/adj. EBITDA ratio < 1.5x at end-2025 remains unchanged 2024 Guidance Deleveraging Forvia Production Outlook Uncertain Environment
BRIEF published on 09/05/2024 at 18:35, 2 years ago FORVIA : Nombre total de droits de vote et d’actions au 31 août 2024 Euronext Paris Droits De Vote Capital Social Actions Forvia
BRIEF published on 09/05/2024 at 18:35, 2 years ago FORVIA: Total number of voting rights and shares as of August 31, 2024 Euronext Paris Share Capital Voting Rights Actions Forvia
PRESS RELEASE published on 09/05/2024 at 18:30, 2 years ago FORVIA : Nombre total de droits de vote et d’actions composant le capital Déclaration des droits de vote et actions composant le capital de l'entreprise cotée à Euronext Paris. Statuts incluent clause de franchissement de seuil Euronext Paris Droits De Vote Actions Statuts Seuil
PRESS RELEASE published on 09/05/2024 at 18:30, 2 years ago FORVIA: Total number of voting rights and shares forming the share capital Nanterre, 5 September 2024 - Total number of voting rights and shares forming the share capital for a company listed on Euronext Paris revealed Euronext Paris Share Capital Voting Rights ISIN Code Nanterre
BRIEF published on 09/03/2024 at 09:55, 2 years ago Templeton Global Advisors réduit sa participation dans Forvia Franchissement De Seuil AMF Forvia Marché Actions Templeton Global Advisors
BRIEF published on 09/03/2024 at 09:55, 2 years ago Templeton Global Advisors reduces stake in Forvia AMF Stock Market Threshold Crossing Forvia Templeton Global Advisors
PRESS RELEASE published on 09/03/2024 at 09:50, 2 years ago Franchissement de seuil Déclaration de franchissement de seuil par Templeton Global Advisors pour FORVIA, 29 août 2024 Capital Franchissement De Seuil AMF Forvia Templeton Global Advisors
BRIEF published on 08/05/2024 at 08:35, 2 years 1 month ago FORVIA: Total Number of Voting Rights and Shares for 2024 Euronext Paris Voting Rights Shares Forvia Faurecia
BRIEF published on 08/05/2024 at 08:35, 2 years 1 month ago FORVIA : Nombre total de droits de vote et d'actions pour 2024 Euronext Paris Actions Droit De Vote Forvia Faurecia
Published on 09/12/2026 at 02:35, 11 hours 13 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 48 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 43 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 23 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 48 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours 18 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 33 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 38 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 18 hours 3 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 33 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
